Company: HROW
Filing Date: 2025-09-08
Form Type: 8-K
Source: 0001493152-25-012778
Chunk: 3

Company: HARROW, INC.
Filing Date: 2025-09-08
Form: 8-K
Item: Item 2.03
Chunk 3
---
 Inc. (“ Melt”) not already owned by the Company. As of June 30, 2025, the Company owned approximately
45% of Melt’s outstanding equity and also has a mid-single digit royalty on future net sales of Melt’s primary product (MELT-300).
Certain officers and directors of the Company, including Mark L. Baum, the Company’s Chairman and Chief Executive Officer, and
Andrew R. Boll, the Company’s President and Chief Financial Officer, own additional interests in Melt. Pursuant to the IOI,
the Company would acquire the remaining equity interests of Melt in exchange for an initial cash payment of approximately $4.3 million
at closing and contingent consideration consisting of cash and Company equity upon achievement of (i) FDA-approval of the MELT-300 product
candidate, (ii) coding and reimbursement of the MELT-300 product candidate, and (iii) various one-time sales milestones. The acquisition
is subject to negotiation of definitive transaction agreements, diligence, and other conditions. There can be no assurance that an acquisition
of Melt will be completed on the terms contemplated or at all, and no assurance as to the potential timing of an acquisition.

A
copy of the press release with respect to the launch of the Offering and other matters is attached to this Current Report on Form 8-K
as Exhibit 99.1

This
Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act, including,
without limitation, statements regarding the Offering and the expected use of proceeds therefrom, the redemption of the 2026
Notes and the 2027 Notes, prepayment of the Oaktree Loan, entry into the New Revolving Credit Facility and completion of the Melt acquisition.
These statements are based on currently available operating, financial, economic and other information, and are subject to a number of
significant risks and uncertainties. A variety of factors, many of which are beyond our control, could cause actual future results to
differ materially from those projected in the forward-looking statements. Specific factors that might cause such a difference include,
but are not limited to: changes in market conditions, negotiation of final transaction documents, changes in operations, business, financial
or other conditions relevant to the planned transactions, and other execution risks related to the completion of the transactions described
herein, as well as other risks detailed in our filings with the Securities and Exchange Commission. We believe these forward